Seres Therapeutics is a clinical-stage biotechnology company focused on developing microbiome-based therapeutics, a class of drugs built from live bacterial consortia designed to modulate the human ...
AstraZeneca has teamed up with Seres Therapeutics to explore whether microbiome therapeutics can increase the efficacy of cancer immunotherapies. The deal will see AstraZeneca pay $20 million to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results